Immediately postoperatively, corneal graft displacement and peripheral corneal edema which remained stable during the first postoperative month were evident on slit lamp examination. Three months ...
a non-surgical cell therapy for corneal edema. The randomized, double-masked trial demonstrated significant improvements in vision and corneal health, alongside a strong safety profile.
an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction. AURN001 is a combination cell therapy product candidate comprised of ...